Image-ID # 1452
In the case of existing technologies that have been in operation for a long time, it is worth analyzing the benefits and the areas where the improvements required for AI (e.g. retrofitting sensors, digitalization) are worthwhile, said Attila Szénási, Director of Pharmaceutical manufacturing at Gedeon Richter Plc.
Reproduction for press purposes free of charge with credit “Picture: Bosch”
